Skip to content

Feline Panleukopenia (FPV) Testing: Complete Guide

Feline panleukopenia virus (FPV) is a highly contagious parvovirus causing severe enteritis and panleukopenia in cats — especially kittens. It is closely related to canine parvovirus (CPV), and rapid antigen testing is the diagnostic mainstay.

When to Test

Signal Action
Acute vomiting/diarrhea + fever (especially kitten) Test immediately
Sudden death or illness in a cattery/litter Test + outbreak protocol
Unexplained leukopenia Test
Pre-intake screening (shelter) Test per protocol

Detection: Antigen

FPV is detected via antigen (fecal), analogous to CPV testing. The virus sheds heavily in feces during acute infection, and antigen positivity tracks active viral shedding.

Sample Collection

  • Preferred sample: fresh fecal swab (rectal or fresh stool).
  • Timing: collect at first clinical signs — shedding peaks early in the disease course.
  • Volume: adequate fecal material; avoid over-dilution.

Result Interpretation

Result Interpretation
Antigen positive + clinical signs Consistent with panleukopenia → isolate + supportive care
Antigen negative, high suspicion Retest in 24 h; shedding may be intermittent
Antigen positive, recently vaccinated Possible transient vaccine-induced positive — correlate clinically

Vaccination Interference

Modified-live FPV vaccines can produce transient antigen positivity for days to weeks post-vaccination. Interpret positives in recently vaccinated, clinically normal cats with caution.

Clinical Decision Flow

Suspected FPV (vomiting/diarrhea/fever, kitten)
Antigen test (fecal) ── positive ──→ Isolate + intensive supportive care
        ↓ negative
High clinical suspicion? ── yes ──→ Retest in 24 h + treat presumptively
        ↓ no
Pursue alternative diagnosis (GI foreign body, toxicity, other enteritis)

Key point: in a sick kitten with compatible signs, a negative antigen does not rule out FPV — treat presumptively while awaiting retest.

Prognosis & Triage

Factor Implication
Early diagnosis + aggressive fluid therapy Improved survival
Profound leukopenia Guarded prognosis
Kittens < 8 weeks Higher mortality

FPV vs CPV — Why It Matters

FPV and CPV are closely related parvoviruses. Some assays cross-react — confirm your assay's specificity, and note that FPV is the more severe feline pathogen. See Canine Parvovirus (CPV) Testing.

FAQ

How fast is the result? ~15 minutes on the Migibio platform.

What is the prognosis for panleukopenia? Guarded in kittens; early detection and aggressive supportive care improve survival.

Does a negative rule out FPV? No — intermittent shedding can yield a false negative; retest if suspicion is high.

Case Study: The Cattery Outbreak

A 10-week-old kitten in a multi-cat household presents acutely with vomiting, profuse diarrhea, and lethargy. Two littermates died the previous week with similar signs.

  • FPV antigen (fecal): positive.
  • Complete blood count: severe leukopenia (WBC 0.8 × 10⁹/L).
  • SAA (feline serum amyloid A): markedly elevated — consistent with systemic inflammation.

Management: Immediate isolation of the affected kitten, intensive intravenous fluid therapy, antiemetics, and broad-spectrum antibiotic cover for secondary bacterial translocation. The cattery initiated an outbreak protocol: quarantine of exposed cats and vaccination review.

Lesson: In a multi-cat setting, one confirmed FPV case is an outbreak signal. The same-visit antigen result triggered isolation and supportive care within the hour, while SAA provided an objective, monitorable inflammation marker during recovery.

References

  1. Barrs VR. Feline Panleukopenia: A Re-emergent Disease. Vet Clin North Am Small Anim Pract. 2019;49(4):651-670. PMID: 30967253
  2. European Advisory Board on Cat Diseases (ABCD). Feline Panleukopenia — Guidelines. abcdcatsvets.org
  3. Greene CE. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012. (Parvoviruses chapter)

For the review policy, see the Editorial & Review Policy.

Authored by: Migibio Clinical & Scientific Affairs, Guangzhou Magic Biotech Co., Ltd.

Reviewed by: Migibio R&D Quality Committee

Last updated: 2026-08-14

Disclosure: Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents referenced in this content. See our Editorial & Review Policy.

Contact: Martin.Wong  ·  Phone (WhatsApp): +86 13323237275  ·  Email: [email protected]
Back to top